This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holler, N.
Right arrow Articles by Tschopp, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holler, N.
Right arrow Articles by Tschopp, J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 2003, p. 1428-1440, Vol. 23, No. 4
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.4.1428-1440.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Two Adjacent Trimeric Fas Ligands Are Required for Fas Signaling and Formation of a Death-Inducing Signaling Complex

Nils Holler,1 Aubry Tardivel,1 Magdalena Kovacsovics-Bankowski,1 Sylvie Hertig,1 Olivier Gaide,1 Fabio Martinon,1 Antoine Tinel,1 David Deperthes,1 Silvio Calderara,2 Therese Schulthess,3 Jürgen Engel,3 Pascal Schneider,1* and Jürg Tschopp1

Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne,1 Apotech Corporation, CH-1066 Epalinges,2 Biozentrum, CH-4000 Basel, Switzerland3

Received 30 August 2002/ Returned for modification 1 October 2002/ Accepted 21 November 2002

The membrane-bound form of Fas ligand (FasL) signals apoptosis in target cells through engagement of the death receptor Fas, whereas the proteolytically processed, soluble form of FasL does not induce cell death. However, soluble FasL can be rendered active upon cross-linking. Since the minimal extent of oligomerization of FasL that exerts cytotoxicity is unknown, we engineered hexameric proteins containing two trimers of FasL within the same molecule. This was achieved by fusing FasL to the Fc portion of immunoglobulin G1 or to the collagen domain of ACRP30/adiponectin. Trimeric FasL and hexameric FasL both bound to Fas, but only the hexameric forms were highly cytotoxic and competent to signal apoptosis via formation of a death-inducing signaling complex. Three sequential early events in Fas-mediated apoptosis could be dissected, namely, receptor binding, receptor activation, and recruitment of intracellular signaling molecules, each of which occurred independently of the subsequent one. These results demonstrate that the limited oligomerization of FasL, and most likely of some other tumor necrosis factor family ligands such as CD40L, is required for triggering of the signaling pathways.

* Corresponding author. Mailing address: Institute of Biochemistry, University of Lausanne, Ch. des Boveresses 155, CH-1066 Epalinges, Switzerland. Phone: 41 21 692 5709. Fax: 41 21 692 5705. E-mail: pascal.schneider{at}ib.unil.ch.

Molecular and Cellular Biology, February 2003, p. 1428-1440, Vol. 23, No. 4
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.4.1428-1440.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kimberley, F. C., van Bostelen, L., Cameron, K., Hardenberg, G., Marquart, J. A., Hahne, M., Medema, J. P. (2009). The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J. 23: 1584-1595 [Abstract] [Full Text]  
  • Verbrugge, I., Wissink, E. H.J., Rooswinkel, R. W., Jongsma, J., Beltraminelli, N., Dupuis, M., Borst, J., Verheij, M. (2009). Combining Radiotherapy with APO010 in Cancer Treatment. Clin. Cancer Res. 15: 2031-2038 [Abstract] [Full Text]  
  • Engedal, N., Auberger, P., Blomhoff, H. K. (2009). Retinoic acid regulates Fas-induced apoptosis in Jurkat T cells: reversal of mitogen-mediated repression of Fas DISC assembly. J. Leukoc. Biol. 85: 469-480 [Abstract] [Full Text]  
  • Anathy, V., Aesif, S. W., Guala, A. S., Havermans, M., Reynaert, N. L., Ho, Y.-S., Budd, R. C., Janssen-Heininger, Y. M.W. (2009). Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas. JCB 184: 241-252 [Abstract] [Full Text]  
  • Fan, C.-Y., Huang, C.-C., Chiu, W.-C., Lai, C.-C., Liou, G.-G., Li, H.-C., Chou, M.-Y. (2008). Production of multivalent protein binders using a self-trimerizing collagen-like peptide scaffold. FASEB J. 22: 3795-3804 [Abstract] [Full Text]  
  • Vince, J. E., Chau, D., Callus, B., Wong, W. W.-L., Hawkins, C. J., Schneider, P., McKinlay, M., Benetatos, C. A., Condon, S. M., Chunduru, S. K., Yeoh, G., Brink, R., Vaux, D. L., Silke, J. (2008). TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNF{alpha}. JCB 182: 171-184 [Abstract] [Full Text]  
  • Tu, W., Lau, Y.-L., Zheng, J., Liu, Y., Chan, P.-L., Mao, H., Dionis, K., Schneider, P., Lewis, D. B. (2008). Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood 112: 2554-2562 [Abstract] [Full Text]  
  • Roosnek, E., Schneider, P., Huard, B. (2008). Heparan sulfate proteoglycans, Fc receptors, and DC suppression. Blood 112: 915-916 [Full Text]  
  • Krippner-Heidenreich, A., Grunwald, I., Zimmermann, G., Kuhnle, M., Gerspach, J., Sterns, T., Shnyder, S. D., Gill, J. H., Mannel, D. N., Pfizenmaier, K., Scheurich, P. (2008). Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity. J. Immunol. 180: 8176-8183 [Abstract] [Full Text]  
  • Zhou, Z., Song, X., Berezov, A., Zhang, G., Li, Y., Zhang, H., Murali, R., Li, B., Greene, M. I. (2008). Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states. Proc. Natl. Acad. Sci. USA 105: 5465-5470 [Abstract] [Full Text]  
  • Bossen, C., Cachero, T. G., Tardivel, A., Ingold, K., Willen, L., Dobles, M., Scott, M. L., Maquelin, A., Belnoue, E., Siegrist, C.-A., Chevrier, S., Acha-Orbea, H., Leung, H., Mackay, F., Tschopp, J., Schneider, P. (2008). TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 111: 1004-1012 [Abstract] [Full Text]  
  • Farley, S. M., Purdy, D. E., Ryabinina, O. P., Schneider, P., Magun, B. E., Iordanov, M. S. (2008). Fas Ligand-induced Proinflammatory Transcriptional Responses in Reconstructed Human Epidermis: RECRUITMENT OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND ACTIVATION OF MAP KINASES. J. Biol. Chem. 283: 919-928 [Abstract] [Full Text]  
  • Willett, B. J., McMonagle, E. L., Logan, N., Spiller, O. B., Schneider, P., Hosie, M. J. (2007). Probing the Interaction between Feline Immunodeficiency Virus and CD134 by Using the Novel Monoclonal Antibody 7D6 and the CD134 (Ox40) Ligand. J. Virol. 81: 9665-9679 [Abstract] [Full Text]  
  • Chen, J., Chen, L., Wang, G., Tang, H. (2007). Cholesterol-Dependent and -Independent CD40 Internalization and Signaling Activation in Cardiovascular Endothelial Cells. Arterioscler. Thromb. Vasc. Bio. 27: 2005-2013 [Abstract] [Full Text]  
  • de Oliveira, G. M., Diniz, R. L., Batista, W., Batista, M. M., Bani Correa, C., de Araujo-Jorge, T. C., Henriques-Pons, A. (2007). Fas Ligand-Dependent Inflammatory Regulation in Acute Myocarditis Induced by Trypanosoma cruzi Infection. Am. J. Pathol. 171: 79-86 [Abstract] [Full Text]  
  • Preynat-Seauve, O., Contassot, E., Schuler, P., Piguet, V., French, L. E., Huard, B. (2007). Extralymphatic Tumors Prepare Draining Lymph Nodes to Invasion via a T-Cell Cross-Tolerance Process. Cancer Res. 67: 5009-5016 [Abstract] [Full Text]  
  • Dranitzki-Elhalel, M., Huang, J. H., Sasson, M., Rachmilewitz, J., Parnas, M., Tykocinski, M. L. (2007). CD40{middle dot}FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism. Int Immunol 19: 355-363 [Abstract] [Full Text]  
  • Chabaud, S., Sasseville, A. M.-J., Elahi, S. M., Caron, A., Dufour, F., Massie, B., Langelier, Y. (2007). The ribonucleotide reductase domain of the R1 subunit of herpes simplex virus type 2 ribonucleotide reductase is essential for R1 antiapoptotic function. J. Gen. Virol. 88: 384-394 [Abstract] [Full Text]  
  • Krysov, S. V., Rowley, T. F., Al-Shamkhani, A. (2007). Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells. Molecular Cancer Therapeutics 6: 703-711 [Abstract] [Full Text]  
  • Beneteau, M., Daburon, S., Moreau, J.-F., Taupin, J.-L., Legembre, P. (2007). Dominant-Negative Fas Mutation Is Reversed by Down-expression of c-FLIP. Cancer Res. 67: 108-115 [Abstract] [Full Text]  
  • Schwaller, J., Schneider, P., Mhawech-Fauceglia, P., McKee, T., Myit, S., Matthes, T., Tschopp, J., Donze, O., Le Gal, F.-A., Huard, B. (2007). Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood 109: 331-338 [Abstract] [Full Text]  
  • Stone, G. W., Barzee, S., Snarsky, V., Spina, C. A., Lifson, J. D., Pillai, V. K. B., Amara, R. R., Villinger, F., Kornbluth, R. S. (2006). Macaque Multimeric Soluble CD40 Ligand and GITR Ligand Constructs Are Immunostimulatory Molecules In Vitro. CVI 13: 1223-1230 [Abstract] [Full Text]  
  • Chang, S. K., Arendt, B. K., Darce, J. R., Wu, X., Jelinek, D. F. (2006). A role for BLyS in the activation of innate immune cells. Blood 108: 2687-2694 [Abstract] [Full Text]  
  • Lukashev, M., LePage, D., Wilson, C., Bailly, V., Garber, E., Lukashin, A., Ngam-ek, A., Zeng, W., Allaire, N., Perrin, S., Xu, X., Szeliga, K., Wortham, K., Kelly, R., Bottiglio, C., Ding, J., Griffith, L., Heaney, G., Silverio, E., Yang, W., Jarpe, M., Fawell, S., Reff, M., Carmillo, A., Miatkowski, K., Amatucci, J., Crowell, T., Prentice, H., Meier, W., Violette, S. M., Mackay, F., Yang, D., Hoffman, R., Browning, J. L. (2006). Targeting the Lymphotoxin-{beta} Receptor with Agonist Antibodies as a Potential Cancer Therapy. Cancer Res. 66: 9617-9624 [Abstract] [Full Text]  
  • Bossen, C., Ingold, K., Tardivel, A., Bodmer, J.-L., Gaide, O., Hertig, S., Ambrose, C., Tschopp, J., Schneider, P. (2006). Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human. J. Biol. Chem. 281: 13964-13971 [Abstract] [Full Text]  
  • Bremer, E., Cate, B. t., Samplonius, D. F., de Leij, L. F. M. H., Helfrich, W. (2006). CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia. Blood 107: 2863-2870 [Abstract] [Full Text]  
  • Cahuzac, N., Baum, W., Kirkin, V., Conchonaud, F., Wawrezinieck, L., Marguet, D., Janssen, O., Zornig, M., Hueber, A.-O. (2006). Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity. Blood 107: 2384-2391 [Abstract] [Full Text]  
  • Stone, G. W., Barzee, S., Snarsky, V., Kee, K., Spina, C. A., Yu, X.-F., Kornbluth, R. S. (2006). Multimeric Soluble CD40 Ligand and GITR Ligand as Adjuvants for Human Immunodeficiency Virus DNA Vaccines. J. Virol. 80: 1762-1772 [Abstract] [Full Text]  
  • Li, F.-Y., Jeffrey, P. D., Yu, J. W., Shi, Y. (2006). Crystal Structure of a Viral FLIP: INSIGHTS INTO FLIP-MEDIATED INHIBITION OF DEATH RECEPTOR SIGNALING. J. Biol. Chem. 281: 2960-2968 [Abstract] [Full Text]  
  • Ii, M., Yamamoto, H., Adachi, Y., Maruyama, Y., Shinomura, Y. (2006). Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis. Exp. Biol. Med. 231: 20-27 [Abstract] [Full Text]  
  • Rabu, C., Quemener, A., Jacques, Y., Echasserieau, K., Vusio, P., Lang, F. (2005). Production of Recombinant Human Trimeric CD137L (4-1BBL): CROSS-LINKING IS ESSENTIAL TO ITS T CELL CO-STIMULATION ACTIVITY. J. Biol. Chem. 280: 41472-41481 [Abstract] [Full Text]  
  • Baum, W., Kirkin, V., Fernandez, S. B. M., Pick, R., Lettau, M., Janssen, O., Zornig, M. (2005). Binding of the Intracellular Fas Ligand (FasL) Domain to the Adaptor Protein PSTPIP Results in a Cytoplasmic Localization of FasL. J. Biol. Chem. 280: 40012-40024 [Abstract] [Full Text]  
  • Liu, J., Zhao, M. Q., Xu, L., Ramana, C. V., Declercq, W., Vandenabeele, P., Enelow, R. I. (2005). Requirement for Tumor Necrosis Factor-Receptor 2 in Alveolar Chemokine Expression Depends upon the Form of the Ligand. Am. J. Respir. Cell Mol. Bio. 33: 463-469 [Abstract] [Full Text]  
  • Manna, P. P., Dimitry, J., Oldenborg, P.-A., Frazier, W. A. (2005). CD47 Augments Fas/CD95-mediated Apoptosis. J. Biol. Chem. 280: 29637-29644 [Abstract] [Full Text]  
  • Yang, J.-Y., Walicki, J., Michod, D., Dubuis, G., Widmann, C. (2005). Impaired Akt Activity Down-Modulation, Caspase-3 Activation, and Apoptosis in Cells Expressing a Caspase-resistant Mutant of RasGAP at Position 157. Mol. Biol. Cell 16: 3511-3520 [Abstract] [Full Text]  
  • Ingold, K., Zumsteg, A., Tardivel, A., Huard, B., Steiner, Q.-G., Cachero, T. G., Qiang, F., Gorelik, L., Kalled, S. L., Acha-Orbea, H., Rennert, P. D., Tschopp, J., Schneider, P. (2005). Identification of proteoglycans as the APRIL-specific binding partners. JEM 201: 1375-1383 [Abstract] [Full Text]  
  • Henkler, F., Behrle, E., Dennehy, K. M., Wicovsky, A., Peters, N., Warnke, C., Pfizenmaier, K., Wajant, H. (2005). The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability. JCB 168: 1087-1098 [Abstract] [Full Text]  
  • Frangsmyr, L., Baranov, V., Nagaeva, O., Stendahl, U., Kjellberg, L., Mincheva-Nilsson, L. (2005). Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod 11: 35-41 [Abstract] [Full Text]  
  • French, L. E., Huard, B., Wysocka, M., Shane, R., Contassot, E., Arrighi, J.-F., Piguet, V., Calderara, S., Rook, A. H. (2005). Impaired CD40L signaling is a cause of defective IL-12 and TNF-{alpha} production in Sezary syndrome: circumvention by hexameric soluble CD40L. Blood 105: 219-225 [Abstract] [Full Text]  
  • Thomas, L. R., Johnson, R. L., Reed, J. C., Thorburn, A. (2004). The C-terminal Tails of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Fas Receptors Have Opposing Functions in Fas-associated Death Domain (FADD) Recruitment and Can Regulate Agonist-specific Mechanisms of Receptor Activation. J. Biol. Chem. 279: 52479-52486 [Abstract] [Full Text]  
  • Yang, J.-Y., Michod, D., Walicki, J., Murphy, B. M., Kasibhatla, S., Martin, S. J., Widmann, C. (2004). Partial Cleavage of RasGAP by Caspases Is Required for Cell Survival in Mild Stress Conditions. Mol. Cell. Biol. 24: 10425-10436 [Abstract] [Full Text]  
  • Thomas, L. R., Henson, A., Reed, J. C., Salsbury, F. R., Thorburn, A. (2004). Direct Binding of Fas-associated Death Domain (FADD) to the Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor DR5 Is Regulated by the Death Effector Domain of FADD. J. Biol. Chem. 279: 32780-32785 [Abstract] [Full Text]  
  • Kassis, R., Larrous, F., Estaquier, J., Bourhy, H. (2004). Lyssavirus Matrix Protein Induces Apoptosis by a TRAIL-Dependent Mechanism Involving Caspase-8 Activation. J. Virol. 78: 6543-6555 [Abstract] [Full Text]  
  • Takemura, Y., Fukuo, K., Yasuda, O., Inoue, T., Inomata, N., Yokoi, T., Kawamoto, H., Suhara, T., Ogihara, T. (2004). Fas Signaling Induces Akt Activation and Upregulation of Endothelial Nitric Oxide Synthase Expression. Hypertension 43: 880-884 [Abstract] [Full Text]  
  • Huard, B., Arlettaz, L., Ambrose, C., Kindler, V., Mauri, D., Roosnek, E., Tschopp, J., Schneider, P., French, L. E. (2004). BAFF production by antigen-presenting cells provides T cell co-stimulation. Int Immunol 16: 467-475 [Abstract] [Full Text]  
  • Tsao, T.-S., Tomas, E., Murrey, H. E., Hug, C., Lee, D. H., Ruderman, N. B., Heuser, J. E., Lodish, H. F. (2003). Role of Disulfide Bonds in Acrp30/Adiponectin Structure and Signaling Specificity: DIFFERENT OLIGOMERS ACTIVATE DIFFERENT SIGNAL TRANSDUCTION PATHWAYS. J. Biol. Chem. 278: 50810-50817 [Abstract] [Full Text]  
  • Samel, D., Muller, D., Gerspach, J., Assohou-Luty, C., Sass, G., Tiegs, G., Pfizenmaier, K., Wajant, H. (2003). Generation of a FasL-based Proapoptotic Fusion Protein Devoid of Systemic Toxicity due to Cell-surface Antigen-restricted Activation. J. Biol. Chem. 278: 32077-32082 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»